Reciprocal effects of NNK and SLURP-1 on oncogene expression in target epithelial cells

Life Sciences

Volumn 91, Issue 21-22, 2012, Pages 1122-1125

  Kalantari Dehaghi, Mina ^a   Bernard, Hans Ulrich ^b   Grando, Sergei A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

BEP2D cells; Gene expression; Head and neck cancers; Het 1A cells; Lung cancer; NNK (4 (methylnitrosamino) 1 (3 pyridyl) 1 butanone); SLURP 1 (secreted mammalian Ly 6 urokinase plasminogen activator receptor related protein 1)

Indexed keywords

NICOTINERGIC SECRETED MAMMALIAN LYSINE 6; NITROSAMINE; RECOMBINANT UROKINASE; UNCLASSIFIED DRUG; UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR RELATED PROTEIN 1; 4 (METHYLNITROSAMINO) 1 (3 PYRIDYL) 1 BUTANONE; 4-(N-METHYL-N-NITROSAMINO)-1-(3-PYRIDYL)-1-BUTANONE; ARS PROTEIN, HUMAN; CARCINOGEN; LY ANTIGEN; UROKINASE;

BRONCHUS; CARCINOGENESIS; CELL IMMORTALIZATION; CELL LINE; CONFERENCE PAPER; DRUG EFFECT; EPITHELIUM CELL; GENE EXPRESSION; GENE TARGETING; HUMAN; HUMAN CELL; MOLECULAR MECHANICS; MOUTH MUCOSA; ONCOGENE; RECEPTOR DOWN REGULATION; RECEPTOR UPREGULATION; TARGET CELL; ARTICLE; CELL TRANSFORMATION; CHEMICALLY INDUCED DISORDER; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; METABOLISM; MOUTH; MOUTH TUMOR; PATHOLOGY; TUMOR CELL LINE;

MAMMALIA; NICOTIANA TABACUM;

ANTIGENS, LY; BRONCHI; CARCINOGENS; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MOUTH; MOUTH NEOPLASMS; NITROSAMINES; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84872805666     PISSN: 00243205     EISSN: 18790631     Source Type: Journal    
DOI: 10.1016/j.lfs.2012.02.004     Document Type: Conference Paper

References (17)

1. C.I. Amos, X. Wu, P. Broderick, I.P. Gorlov, J. Gu, and T. Eisen Genome-wide association scan of tag SNPs identifies a susceptibility locus for lung cancer at 15q25.1 Nat Genet 40 2008 616 622
2. J. Arredondo, A.I. Chernyavsky, R.J. Webber, and S.A. Grando Biological effects of SLURP-1 on human keratinocytes J Invest Dermatol 125 2005 1236 1241
3. J. Arredondo, A.I. Chernyavsky, and S.A. Grando The nicotinic receptor antagonists abolish pathobiologic effects of tobacco-derived nitrosamines on BEP2D cells J Cancer Res Clin Oncol 132 2006 653 663
4. J. Arredondo, A.I. Chernyavsky, and S.A. Grando Nicotinic receptors mediate tumorigenic action of tobacco-derived nitrosamines on immortalized oral epithelial cells Cancer Biol Ther 5 2006 511 517
5. A.I. Chernyavsky, J. Arredondo, D.J. Putney, J.S. Marsh, and S.A. Grando Potential role for epithelial nicotinic receptors in tobacco related oral and lung cancers J Stomatol Investig 2 2008 5 14
6. A. Chikova, and S.A. Grando Naturally occurring variants of human α9 nicotinic receptor differentially affect bronchial cell proliferation and transformation PLoS One 6 2011 e27978
7. F. Chimienti, R.C. Hogg, L. Plantard, C. Lehmann, N. Brakch, and J. Fischer Identification of SLURP-1 as an epidermal neuromodulator explains the clinical phenotype of Mal de Meleda Hum Mol Genet 12 2003 3017 3024
8. N. Faumont, S. Durand-Panteix, M. Schlee, S. Gromminger, M. Schuhmacher, and M. Holzel c-Myc and Rel/NF-kappaB are the two master transcriptional systems activated in the latency III program of Epstein-Barr virus-immortalized B cells J Virol 83 2009 5014 5027
9. S.A. Grando Basic and clinical aspects of non-neuronal acetylcholine: biological and clinical significance of non-canonical ligands of epithelial nicotinic acetylcholine receptors J Pharmacol Sci 106 2008 174 179
10. S.S. Hecht, S.G. Carmella, P.G. Foiles, S.E. Murphy, and L.A. Peterson Tobacco-specific nitrosamine adducts: studies in laboratory animals and humans Environ Health Perspect 99 1993 57 63
11. D. Kaur-Knudsen, S.E. Bojesen, A. Tybjaerg-Hansen, and B.G. Nordestgaard Nicotinic acetylcholine receptor polymorphism, smoking behavior, and tobacco-related cancer and lung and cardiovascular diseases: a cohort study J Clin Oncol 29 2011 2875 2882
12. V.A. Murrah, E.P. Gilchrist, and M.P. Moyer Morphologic and growth effects of tobacco-associated chemical carcinogens and smokeless tobacco extracts on human oral epithelial cells in culture Oral Surg Oral Med Oral Pathol. 75 1993 323 332
13. L. Paleari, E. Negri, A. Catassi, M. Cilli, D. Servent, and R. D'Angelillo Inhibition of nonneuronal alpha7-nicotinic receptor for lung cancer treatment Am J Respir Crit Care Med 179 2009 1141 1150
14. P. Russo, A. Catassi, A. Cesario, and D. Servent Development of novel therapeutic strategies for lung cancer: targeting the cholinergic system Curr Med Chem 13 2006 3493 3512
15. H.M. Schuller Is cancer triggered by altered signalling of nicotinic acetylcholine receptors? Nat Rev Cancer 9 2009 195 205
16. S. Singh, S. Pillai, and S. Chellappan Nicotinic acetylcholine receptor signaling in tumor growth and metastasis J Oncol 2011 2011 456743
17. C.H. Wu, C.H. Lee, and Y.S. Ho Nicotinic acetylcholine receptor-based blockade: applications of molecular targets for cancer therapy Clin Cancer Res 17 2011 3533 3541